These CLS require the user to calculate insulin doses for meals and need ongoing healthcare provider input for optimization, therefore may not be suitable for the wider population with T2D, and there may be insufficient healthcare provider resources to meet the demand. The gene discussed is INS; the disease is type 2 diabetes mellitus.